What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Twentyeight-Seven Therapeutics launches with $65m to develop RNA-modulating cancer therapies In an ambitious move within the biotechnology sector, a new U.S. biotech company, Twentyeight-Seven Therapeutics (28-7), has been… bypharmanewsdailySeptember 9, 2018
